| Heading: |
Prescription Drugs: Supply Chains |
| Question ID: |
1811822 |
| UIN: |
59142 |
| House: |
Commons |
| Date tabled: |
2025-06-11 |
| Asking Member ID: |
5157 |
| Asking Member display name: |
Susan Murray
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Susan Murray
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the resilience of international supply chains for pharmaceuticals procured by the NHS; and what steps he is taking to reduce reliance on imports fo |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-18 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Medical supply chains are complex, global, and highly regulated, making them vulnerable to a variety of shocks. The Government actively monitors emerging global and domestic threats to supply resilience and has established processes in place to manage dis... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |